When GLP-1 activates these brain regions, two things happen: You feel full and satisfied, and naturally stop wanting to eat more High-calorie, high-sugar foods feel less appealing the craving for them is turned down A 2014 study used brain scans (fMRI) to show this happening in real time in human volunteers GLP-1 receptor activation actually reduced brain activity in the regions that process hunger and food rewards
At West Texas Bariatrics, we understand the challenges and frustrations that come with weight loss, and we aim to provide the best solutions for our patients
These initiatives demonstrate a willingness to confront the rise of diabetes with strategies based on health promotion, disease detection, and management of the multiple conditions and complications associated with the disease
Stopping GLP-1 medications can amplify these shifts, as your body adjusts to new hunger and metabolic signals
Types of GLP-1 medications GLP-1 therapies are available in several different forms: Once-weekly injections Daily oral or injectable options Combination therapy with insulins Xultophy (insulin degludec + liraglutide) IcoSema (weekly insulin Icodec + Semaglutide) Soliqua (insulin glargine and lixisenatide) How the main GLP-1 drugs compare While all GLP-1 medications work through similar mechanisms, they differ in strength, dosing frequency, weight loss effects, and side-effect profiles
Also contact your provider if you accidentally took two doses too close together and are experiencing severe side effects